In accordance with the myeloid cell data, the increase in the type-2-associated cytokine, IL-4, occurred only after infection as uninfected IL-33-treated mice had equivalent levels of IL-4 relative to controls (Supplementary Fig. 6e). The gene discussed is IL33; the disease is infection.